Perioperative management of myeloproliferative neoplasms: A pan-Canadian physician survey and international expert opinion

Affiliations

• ¹ Division of Hematology, Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.
• ² Groupe Québécois de Recherche sur la LMC et NMP (GQR LMC-NMP)/Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Quebec Research Group, Montreal, Quebec, Canada.
• ³ Division of General Internal Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
• ⁴ Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.
• ⁵ St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
• ⁶ Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
• ⁷ Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
• ⁸ Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
• ⁹ Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada.
• ¹⁰ Department of Oncology, McGill University, Montreal, Quebec, Canada.
• ¹¹ University of Montreal Health Centre, Montreal, Quebec, Canada.
• ¹² Segal Cancer Center, Jewish General Hospital, Montreal, Quebec, Canada.